Analytics and characterization at Cell 2026
Nov 12–13, 2026 London, UK ~800 attendees Website
26 organizations at Cell 2026 present work in analytics and characterization: 18 suppliers and service providers, 5 drug developers and 3 academic, government and non-profit bodies. Between them they bring 35 presentations to the program. Most represented: Bristol Myers Squibb (5 on the program), Autolus (2 on the program), Quell Therapeutics (2 on the program). As of Oct 8, 2026.
Format
Top represented
Showing 1–16 of 26 organizations
| Organization | Cell 2026 Attendance |
|---|---|
Bristol Myers Squibb Princeton, New Jersey | |
Global drugmaker with marketed CAR-T cell therapies alongside medicines for cancer, immunology and cardiovascular disease. | Talk Thu Nov 12 9:25am–9:50am Advanced Technologies Driving The Next Wave Of Gene Therapy Cell and gene therapy Talk Thu Nov 12 10:15am–10:40am Phase Appropriate Analytical Strategies Including Comparability Analytics and characterizationManufacturing and CMC Panel Thu Nov 12 2:40pm–3:05pm Quality Control Strategies In Advanced CGTs Cell and gene therapyAnalytics and characterization Panel Thu Nov 12 2:40pm–3:05pm Where Does Big Pharma Stand In CGTs – And What Comes Next? Cell and gene therapy Talk Thu Nov 12 4:55pm–5:20pm From Vision And Concepts To Practical Execution - An Analytical Strategy And Lifecycle Execution Roadmap To Support Commercial Readiness And Operational Execution Success Analytics and characterizationManufacturing and CMC Talk Thu Nov 12 5:20pm–5:45pm One Lot, One Life: Scaling Hope for Patients with Autologous CART Treatments Cell and gene therapyManufacturing and CMC Talk Fri Nov 13 1:55pm–2:20pm Designing An End-To-End Supply Chain For CGTs Cell and gene therapyManufacturing and CMC |
Autolus London, UK | |
Develops and markets CAR-T cell therapies, including an approved treatment for adult acute lymphoblastic leukaemia. | Talk Thu Nov 12 3:05pm–3:30pm Harnessing Digital PCR For Rapid Sterility Testing Analytics and characterization Panel Thu Nov 12 5:20pm–5:45pm Overcoming Sterility Testing Challenges In CGT Analytical Development Analytics and characterizationCell and gene therapy Talk Fri Nov 13 5:05pm–5:30pm Developing Cutting-Edge Flow-Based Assays For Critical CMC Applications Analytics and characterizationManufacturing and CMC |
Quell Therapeutics London, UK | |
Develops engineered regulatory T-cell therapies for immune-mediated diseases and transplant rejection. | Panel Thu Nov 12 2:40pm–3:05pm Quality Control Strategies In Advanced CGTs Cell and gene therapyAnalytics and characterization Talk Thu Nov 12 5:20pm–5:45pm Lessons Learned From Cross-Team & Multi-Site Collaboration To Improve Assay Transfer & Scalability Analytics and characterization Panel Fri Nov 13 1:55pm–2:20pm Closing The Gap: Connecting Upstream And Downstream Bioprocessing In Cell-Based Therapies Cell culture and upstream processingCell and gene therapy |
NextCell Pharma Huddinge, Sweden | |
Swedish company developing ProTrans, an umbilical cord stem cell therapy for type 1 diabetes, and running a cord blood bank. | Talk Thu Nov 12 9:25am–9:50am Developing A QC Strategy Analytics and characterizationManufacturing and CMC Panel Thu Nov 12 3:05pm–3:30pm |
University of Liverpool Liverpool, UK | |
Research university with work on quality control and potency testing for cell therapies. | Panel Thu Nov 12 2:40pm–3:05pm Quality Control Strategies In Advanced CGTs Cell and gene therapyAnalytics and characterization Talk Thu Nov 12 5:45pm–6:10pm Choice Of Potency Assays For Vascular Cell Therapies Analytics and characterizationCell and gene therapy |
Abselion Cambridge, UK | ◇Bronze Sponsor |
Makes Amperia, a benchtop electrochemical instrument that measures antibody, viral vector and host cell protein levels in unpurified samples. | Talk Fri Nov 13 11:40am–12:05pm |
Thermo Fisher Scientific Waltham, MA | ◇Bronze Sponsor |
Supplies laboratory instruments, reagents, consumables and software, plus pharmaceutical development and manufacturing services, for research, diagnostics and drug production. | Talk Fri Nov 13 2:20pm–2:45pm |
Waters Milford, MA | Presentation & exhibition package |
Makes liquid chromatography and mass spectrometry instruments and software used to characterize biologics, gene therapy vectors and other biopharmaceuticals. | Talk Fri Nov 13 2:20pm–2:45pm |
BlueRock Therapeutics Cambridge, Massachusetts | |
Bayer subsidiary developing cell therapies made from pluripotent stem cells, starting with Parkinson's disease. | Talk Thu Nov 12 3:05pm–3:30pm Uncovering the Analytical Iceberg: From Early Uncertainty to Commercial Readiness for Cell Therapy Analytics and characterizationCell and gene therapy |
M MHRA London, UK | |
UK regulator of medicines, medical devices and blood products, which also sets biological reference standards. | Talk Fri Nov 13 5:30pm–5:55pm Development Of A WHO Approved Phenotypic Flow Standard For Mesenchymal Stromal Cells Analytics and characterizationStem cells, organoids and cell models |
Royal Free London NHS Foundation Trust London, UK | |
NHS hospital trust in north London whose cell, gene and tissue therapeutics centre manufactures early-phase advanced therapies. | Talk Fri Nov 13 2:45pm–3:10pm From First-in-GMP to 300+ Releases: Building QC into Early Phase ATMP Manufacture Cell and gene therapyAnalytics and characterization |
ACROBiosystems Beijing, China | ○Network & Programme Sponsor |
Supplies recombinant proteins, antibodies and assay kits, including GMP-grade reagents, for work from discovery to clinical manufacturing. | Workshop Fri Nov 13 11:15am–12:55pm |
Alphalyse Odense, Denmark | ◇Silver Sponsor |
Contract lab that analyses proteins by mass spectrometry, including host cell protein testing and characterisation of biologics. | Talk Thu Nov 12 9:50am–10:15am |
Beckman Coulter Life Sciences Indianapolis, Indiana | ◇Silver Sponsor |
Makes flow cytometers, cell counters, particle analysers, centrifuges, liquid handlers and genomics tools for research and bioprocess labs. | Talk Thu Nov 12 9:50am–10:15am Choosing the Clone That Scales: Process-Controlled, Fed-Batch Screening of 96 Clones in Parallel with the Cydem VT Automated Clone Screening System Cell line developmentCell culture and upstream processing |
Bio-Rad Hercules, California | ◇Silver Sponsor |
Makes life science research and clinical diagnostic products, including Droplet Digital PCR systems for absolute quantification of DNA and RNA. | Talk Thu Nov 12 12:00pm–12:25pm Precision that Translates: ddPCR from Discovery to Clinic Analytics and characterization |
bioMérieux Marcy-l'Étoile, France | ◇Silver Sponsor |
Makes microbiology quality control tests for cell therapy sites, including rapid sterility, one-hour mycoplasma and endotoxin testing. | Talk Thu Nov 12 12:00pm–12:25pm Validating Rapid Mycoplasma Methods for Cell & Gene Therapies: A roadmap to EP 2.6.7 and USP <77> compliance Analytics and characterizationCell and gene therapy |
Instantly find 20 buyers in analytics and characterization
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse Cell 2026 by
Organization type
Topic
Everyone
Not affiliated with or endorsed by Cell 2026 or its organizers. Submit a correction